UnitedHealth Group heads into third-quarter earnings on Oct. 13 with investors focused on whether the second-quarter rebound in medical costs can hold. UnitedHealthcare's medical care ratio improved to 86.7% in the second quarter from 89.4% a year earlier, operating earnings rose to $3.9 billion from $2.1 billion, and operating margin climbed to 4.6% from 2.4%, though the quarter included $860 million of favorable medical reserve development. Management's 88.1% full-year MCR outlook will be closely watched, along with underlying medical costs, Medicare inpatient and outpatient utilization, commercial cost trends, specialty-drug inflation and provider coding intensity. On Medicare Advantage, membership stood at 7.565 million at June 30, down 785,000 from a year earlier, and management expects the full-year MA decline to reach roughly 1.1 million members, while still expecting Medicare margins to finish 2026 above 3%. Peers Humana and Elevance Health also face rising medical cost trends, with Humana's insurance benefit ratio up 130 basis points to 91.2% and Elevance's benefit expense ratio up 80 basis points to 89.7%. The Zacks Consensus Estimate for UnitedHealth's 2026 earnings is $19.85 per share, implying a 21.4% improvement from the year-ago period.
UnitedHealth Group IncorporatedQ3 preview centers on whether UnitedHealth's Q2 medical cost rebound (MCR 86.7%, operating earnings $3.9B) can hold, with the 88.1% full-year MCR outlook and 2026 EPS estimate of $19.85 in focus.
Humana IncHumana's insurance benefit ratio climbed 130 basis points to 91.2% as medical cost trends rise.
Elevance Health IncElevance's benefit expense ratio rose 80 basis points to 89.7% amid rising medical cost trends, pressuring margins.
